ロード中...

Measuring differential treatment benefit across marker specific subgroups: the choice of outcome scale

Clinical and epidemiological studies of anticancer therapies increasingly seek to identify predictive biomarkers to obtain insights into variation in treatment benefit. For time to event endpoints, a predictive biomarker is typically assessed using the interaction between the biomarker and treatment...

詳細記述

保存先:
書誌詳細
出版年:Contemp Clin Trials
主要な著者: Satagopan, Jaya M., Iasonos, Alexia
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5568905/
https://ncbi.nlm.nih.gov/pubmed/28254404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2017.02.007
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!